# Effects of Gallopamil in Severe Asthma

> **NCT00896428** · PHASE2 · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 31 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Methoxyverapamil (gallopamil)
- **DRUG:** Placebo.

## Key facts

- **NCT ID:** NCT00896428
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-07
- **Final completion:** 2012-11
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2013-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00896428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00896428, "Effects of Gallopamil in Severe Asthma". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00896428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*